Carlsmed (CARL) Revenue (2024 - 2026)

Carlsmed (CARL) has reported Revenue for 3 consecutive years, with $18.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 56.75% year-over-year to $18.9 million; the trailing twelve-month figure through Jun 2026 stood at $63.3 million (up 65.39% YoY), and the FY2025 full-year result was $50.5 million, up 85.94% from the prior year.
• Revenue climbed to $18.9 million in Q2 2026 per CARL's latest filing, from $16.1 million in the prior quarter.
• Across five years, Revenue topped out at $18.9 million in Q2 2026 and bottomed at $6.1 million in Q2 2024.
• Historically, Revenue has averaged $12.0 million across 3 years, with a median of $12.1 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Revenue surged 98.7% in 2025, then soared 56.75% in 2026.
• Over 3 years, Revenue stood at $9.4 million in 2024, then jumped by 61.19% to $15.2 million in 2025, then increased by 24.89% to $18.9 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $18.9 million, $16.1 million, and $15.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.